Oblenio Bio Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $62M

  • Investors
  • 5

Oblenio Bio General Information

Description

Operator of a biotechnology company intended to transform the treatment of severe autoimmune diseases. The company is focused on realizing the significant potential of T-cell engagers as a novel therapeutic approach that addresses underlying disease pathophysiology and enables immune reset, enabling clients to target these therapies across various diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4 Maguire Road
  • Lexington, MA 02421
  • United States
+1 (510)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 4 Maguire Road
  • Lexington, MA 02421
  • United States
+1 (510)

Oblenio Bio Timeline

20252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oblenio Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 25-Jun-2026 $62M Completed Clinical Trials - General
2. Early Stage VC (Series A) Completed Pre-Clinical Trials
1. Joint Venture 07-Nov-2024 Completed Pre-Clinical Trials
To view Oblenio Bio’s complete valuation and funding history, request access »

Oblenio Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-2
Series B-1
Series A-2 1,269,705 $0.000100 2% $4.21 $4.21 1x $4.21 6.21%
Series A-1 7,000,000 $0.000100 2% $4.21 $4.21 1x $4.21 34.25%
To view Oblenio Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Oblenio Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oblenio Bio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Deep Track Capital Venture Capital Minority
GV Corporate Venture Capital Minority
Pfizer Ventures Corporate Venture Capital Minority
Aditum Bio Venture Capital Majority
Leads Biolabs Corporation Majority
To view Oblenio Bio’s complete investors history, request access »

Oblenio Bio FAQs

  • When was Oblenio Bio founded?

    Oblenio Bio was founded in 2024.

  • Where is Oblenio Bio headquartered?

    Oblenio Bio is headquartered in Lexington, MA.

  • What is the size of Oblenio Bio?

    Oblenio Bio has 6 total employees.

  • What industry is Oblenio Bio in?

    Oblenio Bio’s primary industry is Biotechnology.

  • Is Oblenio Bio a private or public company?

    Oblenio Bio is a Private company.

  • What is the current valuation of Oblenio Bio?

    The current valuation of Oblenio Bio is .

  • What is Oblenio Bio’s current revenue?

    The current revenue for Oblenio Bio is .

  • How much funding has Oblenio Bio raised over time?

    Oblenio Bio has raised $96.5M.

  • Who are Oblenio Bio’s investors?

    Deep Track Capital, GV, Pfizer Ventures, Aditum Bio, and Leads Biolabs have invested in Oblenio Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process